Feb. 25, 2013
/PRNewswire/ -- NewLink Genetics Corporation (Nasdaq:NLNK) today announced that its Fourth Quarter and fiscal year ended
December 31, 2012
financial results will be released before the market opens on
Thursday, February 28
, 2013. The NewLink management team will host a conference call discussing the company's financial results and recent corporate developments on
Thursday, February 28, 2013
. The call can be accessed by dialing 1-(877) 363-5052 (domestic) or 1-(914) 495-8600 (international) five minutes prior to the start of the call and providing the passcode 16064630. A replay of the call will be available approximately two hours after the completion of the call and can be accessed by dialing 1-(855) 859-2056 (domestic) or 1-(404) 537-3406 (international), providing the passcode 16064630. The replay will be available for two weeks from the date of the live call.
The live, listen-only webcast of the conference call can be accessed by visiting the investors section of the NewLink website at
. A replay of the webcast will be archived on the company's website for two weeks following the call.
About NewLink Genetics Corporation
NewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians. NewLink's portfolio includes biologic and small-molecule immunotherapy product candidates intended to treat a wide range of oncology indications.
Gordon Link Chief Financial Officer NewLink Genetics 1.515.598.2925
SOURCE NewLink Genetics Corporation